JPMorgan International Research Enhanced Equity ETF (JIRE)
| Assets | $8.08B |
| Expense Ratio | 0.24% |
| PE Ratio | 15.90 |
| Shares Out | 110.48M |
| Dividend (ttm) | $1.77 |
| Dividend Yield | 2.45% |
| Ex-Dividend Date | Dec 24, 2024 |
| Payout Ratio | 39.21% |
| 1-Year Return | +17.17% |
| Volume | 62,800 |
| Open | 71.95 |
| Previous Close | 72.22 |
| Day's Range | 71.95 - 72.29 |
| 52-Week Low | 56.30 |
| 52-Week High | 72.37 |
| Beta | 0.85 |
| Holdings | 226 |
| Inception Date | Jun 10, 2022 |
About JIRE
Fund Home PageThe JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is issued by JPMorgan Chase.
Top 10 Holdings
16.17% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.02% |
| AstraZeneca PLC | AZN | 1.89% |
| Shell plc | SHEL | 1.86% |
| Nestlé S.A. | NESN | 1.71% |
| Siemens Aktiengesellschaft | SIE | 1.61% |
| Allianz SE | ALV | 1.50% |
| Banco Santander, S.A. | SAN | 1.45% |
| SAP SE | SAP | 1.43% |
| Safran SA | SAF | 1.36% |
| UniCredit S.p.A. | UCG | 1.34% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 24, 2024 | $1.77105 | Dec 27, 2024 |
| Dec 19, 2023 | $1.59913 | Dec 22, 2023 |
| Dec 20, 2022 | $1.31061 | Dec 23, 2022 |
News
Fidelity, T. Rowe Price, JPMAM Active International ETFs Outperform EFA
The landscape of international equity ETFs often centers around benchmarks like the MSCI EAFE Index, which measures the performance of developed markets excluding the U.S. and Canada. While passive in...
JIRE: A Reasonable International Bet In An Unsure Domestic Economy
JPMorgan International Research Enhanced Equity ETF launched as an ETF in June 2022 after operating as a mutual fund. JIRE invests in developed markets, with a focus on financials, industrials, health...